solute carrier family 3 member 1
Last updated 2 May 2023
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The SLC3A1 gene provides instructions for producing one part (subunit) of a protein made primarily in the kidneys. This subunit joins with another protein subunit, produced from the SLC7A9 gene, to form a transporter protein complex. During the process of urine formation in the kidneys, this protein complex absorbs particular protein building blocks (amino acids) back into the blood. In particular, the amino acids cystine, ornithine, arginine, and lysine are absorbed back into the blood through this mechanism.
Video picks for GenesVideo library
Normal function
The SLC3A1 gene provides instructions for producing one part (subunit) of a protein made primarily in the kidneys. This subunit joins with another protein subunit, produced from the SLC7A9 gene, to form a transporter protein complex. During the process of urine formation in the kidneys, this protein complex absorbs particular protein building blocks (amino acids) back into the blood. In particular, the amino acids cystine, ornithine, arginine, and lysine are absorbed back into the blood through this mechanism.
Conditions referring to this gene or chromosome
Other names
amino acid transporter 1
ATR1
CSNU1
D2H
NBAT
RBAT
SLC31_HUMAN
solute carrier family 3 (amino acid transporter heavy chain), member 1
solute carrier family 3 (cystine, dibasic and neutral amino acid transporters), member 1
solute carrier family 3 (cystine, dibasic and neutral amino acid transporters, activator of cystine, dibasic and neutral amino acid transport), member 1
solute carrier family 3, member 1
Patient picks for Genes

Podcasts
The parental minefield
How often have you said something quite ordinary to a parent, or they’ve said something to you and suddenly the room feels like it’s about to explode? Welcome to the parental nightmare. It’s not just about conflict, it’s about what’s hidden underneath these relationships – family secrets, unspoken stories, patterns of behaviour passed from one generation to the next. In this episode Clare and Aileen explore the complex, often lifelong, relationship we have with our parents and discuss practical strategies to help you navigate this important relationship.
by Thomas Andrew Porteus, MBCS

Mental health
Not quite 'back to normal': a guide to post-pandemic family healing
When news broke in late 2019 of a virus spreading rapidly across the globe, the word ‘unprecedented’ quickly became part of everyday vocabulary in the months that followed. The outbreak of Covid-19 marked the world’s most significant public health crisis in at least a century, shaking the foundations of the one place we usually feel most secure - the home. It is no surprise that years of disrupted routines have left a lasting mark on the family unit. From the sudden loss of support networks to the blurring of boundaries between home, school, and work, the pandemic reshaped how families function. We spoke with a psychotherapist to explore these long-term psychological ripples and why reflecting on that period is essential for understanding - and healing - the family dynamic today.
by Victoria Raw

Children's health
Pearson syndrome: how one family learned to live in the present
Pearson syndrome is a rare and serious mitochondrial disorder that typically affects infants and young children. There is currently no cure, and it is usually life-threatening. We follow one family’s journey of living with the condition, exploring how it shapes their everyday lives, the challenges they face, and what it truly means to cherish every moment.
by Victoria Raw

Podcasts
What are relationships anyway?
Relationships – what are they? We often think of relationships as intimate with a partner and yet we actually have hundreds of relationships with friends, family, at work, at play even with nature and beyond. Clare and Aileen kick off the season by discussing the breadth of relationships.
by Thomas Andrew Porteus, MBCS

COVID-19
How to meet friends and family safely outdoors
Across the UK, lockdowns are easing and we're allowed to see friends and family outside (and indoors too if you live in England or Scotland). But that doesn't mean the risk of spreading COVID-19 has vanished; you still need to take precautions to keep yourself and your loved ones safe.
by Andrea Downey

COVID-19
COVID-19: how to support vulnerable friends and family during the coronavirus pandemic
Current coronavirus lockdown measures are especially challenging for older people and those with mental health issues and underlying health conditions. We look at how to support vulnerable loved ones during the COVID-19 pandemic.
by Sally Turner
Related patient information and medicines

Patient information leaflet
Wilson's disease
Wilson's disease is a genetic disorder in which copper builds up in the body, mainly in the liver and brain. Without any treatment, the build-up of copper can cause serious symptoms. Treatment is with medication to remove the excess copper and/or to prevent a further build-up of copper. What is Wilson's disease. Wilson's disease is a condition.

Patient information leaflet
Haemochromatosis
Find out more here: [https://patient.info/health/haemochromatosis-leaflet](https://patient.info/health/haemochromatosis-leaflet) People with haemochromatosis have inherited a faulty gene, which directs the body to absorb too much iron from what they eat and drink. Causes of haemochromatosis Haemochromatosis is a genetic condition. It is passed on.

Patient information leaflet
Cystic fibrosis
Cystic fibrosis is a genetic disorder. A ge... How is cystic fibrosis inherited. Cystic fibrosis is an autosomal recessive disorder. This means that in order to develop cystic fibrosis you need to inherit two cystic fibrosis genes, one from your mother and one from your father. If you inherit only one cystic fibrosis gene, you are called a.

Patient information leaflet
Polycystic kidney disease
There are different types of polycystic kidney disease: Autosomal dominant polycystic kidney disease (ADPKD) This is the most common type. This is an hereditary condition caused by a faulty gene which is inherited from one parent. Although people with PKD often develop kidney failure (end-stage kidney disease) between ages 55 to 65 years, some.

Patient information leaflet
Hereditary spherocytosis
Hereditary spherocytosis (HS) is an inherited condition of red blood cells. The disease can be mild and go unrecognised in some people. In others there may be severe anaemia requiring regular blood transfusions. Some people with hereditary spherocytosis may be offered surgery to remove their spleen. This usually helps the condition, but increases.

Patient information leaflet
Duchenne muscular dystrophy
The weakness develops gra... It usually starts to be seen in early childhood. Symptoms are mild at first but increase as the child becomes older. The name Duchenne comes from the doctor who first studied this condition. How common is Duchenne muscular dystrophy. About 1 in 3,500 boys in the UK are born with DMD. There are other types of muscular.
Further reading and references
- solute carrier family 3 member 1; MedlinePlus, National Library of Medicine.
- Chabrol B, Martens K, Meulemans S, Cano A, Jaeken J, Matthijs G, Creemers JW. Deletion of C2orf34, PREPL and SLC3A1 causes atypical hypotonia-cystinuria syndrome. J Med Genet. 2008 May;45(5):314-8. doi: 10.1136/jmg.2007.055475. Epub 2008 Jan 30.
- Dello Strologo L, Pras E, Pontesilli C, Beccia E, Ricci-Barbini V, de Sanctis L, Ponzone A, Gallucci M, Bisceglia L, Zelante L, Jimenez-Vidal M, Font M, Zorzano A, Rousaud F, Nunes V, Gasparini P, Palacin M, Rizzoni G. Comparison between SLC3A1 and SLC7A9 cystinuria patients and carriers: a need for a new classification. J Am Soc Nephrol. 2002 Oct;13(10):2547-53. doi: 10.1097/01.asn.0000029586.17680.e5.
- Fernandez E, Carrascal M, Rousaud F, Abian J, Zorzano A, Palacin M, Chillaron J. rBAT-b(0,+)AT heterodimer is the main apical reabsorption system for cystine in the kidney. Am J Physiol Renal Physiol. 2002 Sep;283(3):F540-8. doi: 10.1152/ajprenal.00071.2002.
- Font-Llitjos M, Jimenez-Vidal M, Bisceglia L, Di Perna M, de Sanctis L, Rousaud F, Zelante L, Palacin M, Nunes V. New insights into cystinuria: 40 new mutations, genotype-phenotype correlation, and digenic inheritance causing partial phenotype. J Med Genet. 2005 Jan;42(1):58-68. doi: 10.1136/jmg.2004.022244.
- Goodyer P. The molecular basis of cystinuria. Nephron Exp Nephrol. 2004;98(2):e45-9. doi: 10.1159/000080255.
- Langman CB. The molecular basis of kidney stones. Curr Opin Pediatr. 2004 Apr;16(2):188-93. doi: 10.1097/00008480-200404000-00013.
- Martens K, Heulens I, Meulemans S, Zaffanello M, Tilstra D, Hes FJ, Rooman R, Francois I, de Zegher F, Jaeken J, Matthijs G, Creemers JW. Global distribution of the most prevalent deletions causing hypotonia-cystinuria syndrome. Eur J Hum Genet. 2007 Oct;15(10):1029-33. doi: 10.1038/sj.ejhg.5201881. Epub 2007 Jun 20.
- Martens K, Jaeken J, Matthijs G, Creemers JW. Multi-system disorder syndromes associated with cystinuria type I. Curr Mol Med. 2008 Sep;8(6):544-50. doi: 10.2174/156652408785747997.
- Schmidt C, Vester U, Wagner CA, Lahme S, Hesse A, Hoyer P, Lang F, Zerres K, Eggermann T; Arbeitsgemeinschaft fur Padiatrische Nephrologie. Significant contribution of genomic rearrangements in SLC3A1 and SLC7A9 to the etiology of cystinuria. Kidney Int. 2003 Nov;64(5):1564-72. doi: 10.1046/j.1523-1755.2003.00250.x.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

